- Home
- XP vs CORT Comparison
XP vs CORT Comparison
Compare XP & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XP
- CORT
- Stock Information
- Founded
- XP 2001
- CORT 1998
- Country
- XP Cayman Islands
- CORT United States
- Employees
- XP N/A
- CORT N/A
- Industry
- XP Investment Bankers/Brokers/Service
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- XP Finance
- CORT Health Care
- Exchange
- XP Nasdaq
- CORT Nasdaq
- Market Cap
- XP 7.5B
- CORT 7.1B
- IPO Year
- XP 2019
- CORT N/A
- Fundamental
- Price
- XP $18.59
- CORT $74.07
- Analyst Decision
- XP Buy
- CORT Strong Buy
- Analyst Count
- XP 6
- CORT 4
- Target Price
- XP $20.83
- CORT $142.00
- AVG Volume (30 Days)
- XP 7.8M
- CORT 1.4M
- Earning Date
- XP 05-27-2025
- CORT 05-05-2025
- Dividend Yield
- XP 3.50%
- CORT N/A
- EPS Growth
- XP 14.90
- CORT 8.36
- EPS
- XP 1.33
- CORT 1.14
- Revenue
- XP $2,627,582,667.00
- CORT $685,446,000.00
- Revenue This Year
- XP $19.66
- CORT $35.85
- Revenue Next Year
- XP $12.78
- CORT $35.22
- P/E Ratio
- XP $14.21
- CORT $64.25
- Revenue Growth
- XP 14.10
- CORT 30.93
- 52 Week Low
- XP $10.82
- CORT $25.35
- 52 Week High
- XP $22.23
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- XP 75.51
- CORT 56.46
- Support Level
- XP $15.51
- CORT $68.86
- Resistance Level
- XP $19.10
- CORT $73.36
- Average True Range (ATR)
- XP 0.48
- CORT 3.16
- MACD
- XP 0.24
- CORT 0.06
- Stochastic Oscillator
- XP 86.75
- CORT 85.76
About XP XP Inc.
XP Inc is a Cayman Island-based technology-driven financial services platform. It is a provider of low-fee financial products and services in Brazil. The company evaluates its business through a single segment such as monitoring operations, making decisions on fund allocation, and evaluating the performance. It generates revenue through the Brokerage commission.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.